Serum thioredoxin is a diagnostic marker for hepatocellular carcinoma

Here we found that serum levels of thioredoxin were increased in patients with hepatocellular carcinoma (HCC). The optimum diagnostic cutoff for thioredoxin was 20.5 ng/mL (area under curve [AUC] 0.946 [95% CI 0.923–0.969] in the training cohort; 0.941 [0.918–0.963] in the validation cohort). High s...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: Li, Jun, Cheng, Zhang-Jun, Liu, Yang, Yan, Zhen-Lin, Wang, Kui, Wu, Dong, Wan, Xu-Ying, Xia, Yong, Lau, Wan Yee, Wu, Meng-Chao, Shen, Feng
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2015
Assuntos:
Clinical Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4496238/
https://ncbi.nlm.nih.gov/pubmed/25871387
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares